In Polyzos’s study, NAFLD patients did not differ in age, BMI, WC, HDL-CH, uric acids and glucose concentration, but had higher AST, ALT, GGTP and TG values than patients without NAFLD. This evidence concerns the gene C4B and metabolic dysfunction-associated steatotic liver disease.